18F-FDG positron emission tomography as a marker of disease activity and treatment response in ankylosing spondylitis and psoriatic arthritis
Scientific Reports · 28.08.2024 · 14 (1)
DOI: 10.1038/s41598-024-60669-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, online erschienen am 28.08.2024. Verfasst von Omar D Rodríguez-Fonseca und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Department, Central University Hospital of Asturias (HUCA), Avenida Roma S/N, 33011, Oviedo, Asturias, Spain. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Arthritis, Psoriatic, Spondylitis, Ankylosing, Positron-Emission Tomography. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The ability of 18F-FDG positron emission tomography (PET) to track disease activity and treatment response in patients with Ankylosing Spondylitis (AS) or Psoriatic Arthritis (PsA) remains unclear. Here, we assessed whether 18F-FDG uptake is a marker of disease activity and treatment response in AS or PsA, and explored the ability of 18F-FDG to predict treatment response. Patients with AS (n = 16) or PsA (n = 8) who were scheduled to initiate treatment with biologics were recruited. Participants underwent a clinical evaluation and an 18F-FDG scan prior to therapy initiation. Eleven participants underwent a follow-up 18F-FDG scan 3 months post-treatment. Images were quantified using a composite measure that describes the inflammatory status of the patient. Clinically involved joints/entheses had higher 18F-FDG uptake compared to unaffected areas (median difference > 0.6, p 8.5, p < 0.001). We found no significant association between pre-treatment 18F-FDG uptake and subsequent clinical response. 18F-FDG PET shows potential as a marker of disease activity in AS and PsA, allowing for monitorization of biological treatment efficacy in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuclear Medicine Department, Central University Hospital of Asturias (HUCA), Avenida Roma S/N, 33011, Oviedo, Asturias, Spain.
- Nuclear Medicine Department, Lucus Augusti University Hospital (HULA), 27003, Lugo, Spain.
- Molecular Imaging Biomarkers and Theragnosis, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela (USC), Campus Vida, Santiago de Compostela, Galicia, Spain. pabl…
- Molecular Imaging Group, Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, Spain. pablo.aguiar.fernandez@sergas.es.
- Nuclear Medicine Department, Central University Hospital of Asturias (HUCA), Avenida Roma S/N, 33011, Oviedo, Asturias, Spain. franciscomanuel.gonzalez@sespa.es.
- Department of Rheumatology, Central University Hospital of Asturias (HUCA), 33011, Oviedo, Asturias, Spain.
Zitieren
APA
Rodríguez-Fonseca, O. D., Aguiar, P., García, F. M. G., Llana, B. F., Díaz, C. V., Grande, M. L. D., Silva, R. Q., Brandy-García, A. M., Castro, S. A., & Hernández, J. C. (2024). 18F-FDG positron emission tomography as a marker of disease activity and treatment response in ankylosing spondylitis and psoriatic arthritis. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-60669-4
Vancouver
Rodríguez-Fonseca OD, Aguiar P, García FMG, Llana BF, Díaz CV, Grande MLD, et al. 18F-FDG positron emission tomography as a marker of disease activity and treatment response in ankylosing spondylitis and psoriatic arthritis. Scientific Reports. 2024;14(1). doi:10.1038/s41598-024-60669-4
BibTeX
@article{RodrguezFonseca2024,
author = {Rodríguez-Fonseca, Omar D and Aguiar, Pablo and García, Francisco M González and Llana, Belén Fernández and Díaz, Carmen Vigil and Grande, María Luz Domínguez and Silva, Rubén Queiro and Brandy-García, Anahy M and Castro, Sara Alonso and Hernández, Julia Cortés},
title = {18F-FDG positron emission tomography as a marker of disease activity and treatment response in ankylosing spondylitis and psoriatic arthritis},
journal = {Scientific Reports},
year = {2024},
volume = {14},
number = {1},
doi = {10.1038/s41598-024-60669-4}
}
EUVIMED